These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11102560)

  • 1. Clinical experience with specific COX-2 inhibitors in arthritis.
    Crofford LJ
    Curr Pharm Des; 2000 Nov; 6(17):1725-36. PubMed ID: 11102560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 specificity and its clinical implications.
    Lefkowith JB
    Am J Med; 1999 May; 106(5B):43S-50S. PubMed ID: 10390127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain management in osteoarthritis: the role of COX-2 inhibitors.
    Lane NE
    J Rheumatol Suppl; 1997 Jul; 49():20-4. PubMed ID: 9249647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of cyclooxygenase-2-specific inhibitors.
    Cannon GW; Breedveld FC
    Am J Med; 2001 Feb; 110 Suppl 3A():6S-12S. PubMed ID: 11173044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with cyclooxygenase-2 inhibitors.
    Lanas A
    Rheumatology (Oxford); 2002 Apr; 41 Supp 1():16-22; discussion 35-42. PubMed ID: 12173276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
    Hochberg MC
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific cyclooxygenase-2 (COX-2) inhibitors.
    Rubin BR
    J Am Osteopath Assoc; 1999 Jun; 99(6):322-5. PubMed ID: 10405519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of COX-2 inhibitors in arthritis.
    Jackson CG
    Expert Opin Investig Drugs; 2001 Jul; 10(7):1317-25. PubMed ID: 11772254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 inhibitors: a new approach to the therapy of ocular inflammation.
    Masferrer JL; Kulkarni PS
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S35-40. PubMed ID: 9154274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unmet anti-inflammatory needs in orthopedics.
    Trippel SB
    Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):3-7. PubMed ID: 10193996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: COX-II inhibitors--a new generation of safer NSAIDs?
    Donnelly MT; Hawkey CJ
    Aliment Pharmacol Ther; 1997 Apr; 11(2):227-36. PubMed ID: 9146759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
    Hochberg MC
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.
    Lee MC; Lee S; Suh DC; Kim J; Kong SX;
    Curr Med Res Opin; 2003; 19(7):597-602. PubMed ID: 14606981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of aspirin-like drugs.
    Vane JR; Botting RM
    Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):2-10. PubMed ID: 9219313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer.
    Yamamoto DS; Viale PH
    Clin J Oncol Nurs; 2003; 7(1):21-9. PubMed ID: 12629931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cyclooxygenase-2 inhibitors: safety and effectiveness.
    Kaplan-Machlis B; Klostermeyer BS
    Ann Pharmacother; 1999 Sep; 33(9):979-88. PubMed ID: 10492503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.